<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105944">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01980862</url>
  </required_header>
  <id_info>
    <org_study_id>FDI-83</org_study_id>
    <nct_id>NCT01980862</nct_id>
  </id_info>
  <brief_title>Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fujirebio Diagnostics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fujirebio Diagnostics, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-site blood collection investigation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      45 Heart Failure patients will be recruited. Patients will provide a one-time blood sample
      specimen collection. Theses samples will be de-identified and provided for measurement of
      Galectin-3 on commercial platforms.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Obtain 45 matched donor serum and plasma samples sets collected from Heart Failure patients for galectin-3 measurements</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>To Measure Galectin-3 in Heart Failure Patients on Commercial Platforms</condition>
  <arm_group>
    <arm_group_label>Heart Failure patients</arm_group_label>
    <description>No interventions for this study. Blood draw provided by patients.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        45 matched door serum and plasma. Samples set collected form individual Heart Failure
        patients for galecin-3 measurements
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Heart Failure patients New York Heart Association class able to provide (4)
             collection tube types Subjects &gt; 18 years old All subjects must provide informed
             consent and associated documentation

        Exclusion Criteria:

          -  Subjects that cannot tolerate blood withdrawal of 4 specimens collection tube tubes
             (approximately 40 mLs)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Christenson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universtiy of Maryland School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica Fugate, CRC</last_name>
    <phone>443 604 1652</phone>
  </overall_contact>
  <location>
    <facility>
      <name>University of Maryland School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Fugate, CRC</last_name>
      <phone>443-604-1652</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 5, 2013</lastchanged_date>
  <firstreceived_date>November 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
